Knight Therapeutics Inc. (KHTRF)
OTC
Closed
Aug 24, 2026
Day's Range
6.9552 wk Range
4.07Overview - KHTRF - Knight Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
433.50M
P/E (Trailing)
‪63.27‬
PEG Ratio
‪-0.25‬
Price / Sales (TTM)
‪1.24‬
Price / Book
‪1.17‬
EV / EBITDA
‪7.35‬
Profitability
Gross Margin
‪48.27%‬
Profit Margin
‪2.71%‬
Operating Margin
‪6.21%‬
Return on Assets
‪1.31%‬
Return on Equity
‪1.90%‬
Ownership
Shares Outstanding
98.22M
Float
60.29M
Held by Insiders
‪46.99%‬
Held by Institutions
‪18.12%‬
Price stats
Beta
‪0.04‬
50-Day Avg
‪6.86‬
200-Day Avg
‪5.37‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KHTRF - Knight Therapeutics Inc.
Peers - KHTRF - Knight Therapeutics Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- KHTRFOTCKnight Therapeutics Inc.683.69MMarket Cap+32.18%52-week change63.27P/E (Trailing)‪2.71%‬Profit Margin
- MKGAFOTCMerck KGaA70.96BMarket Cap+22.06%52-week change23.97P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR70.34BMarket Cap+22.38%52-week change23.71P/E (Trailing)‪11.21%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.66.37BMarket Cap+15.20%52-week change58.82P/E (Trailing)‪86.20%‬Profit Margin
- GDERFOTCGalderma Group AG51.83BMarket Cap+19.81%52-week change57.53P/E (Trailing)‪14.57%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR49.49BMarket Cap+19.32%52-week change58.15P/E (Trailing)‪14.57%‬Profit Margin
- HLNCFOTCHaleon plc42.44BMarket Cap-1.14%52-week change19.24P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - KHTRF - Knight Therapeutics Inc.
About
Knight Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing innovative pharmaceutical products in Latin America and Canada. The company's primary role is to fill therapeutic gaps with a focus on specialty areas such as oncology, infectious diseases, and metabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
